By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – DNA sequencing developer Nabsys said today that it has reeled in $7 million in Series B venture financing in an equity round led by Stata Venture Partners.

The Providence, RI-based firm said it plans to use the financing to speed up development and commercialization of its core platform, which uses semiconductor technology in a solid-state DNA sequencing tool.

In 2009, Nabsys completed a $4 million equity round.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.